ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005


The Latest on Twitter

Kidney Week

Abstract: TH-PO224

Role of DJ-1(PARK7) in Hepcidin-Mediated Protection of AKI in a Murine Model of Sepsis (LPS)

Session Information

Category: Acute Kidney Injury

  • 001 AKI: Basic


  • Leeds, Joseph T., University of Virginia, Charlottesville, Virginia, United States
  • Scindia, Yogesh M., Univerisity of Virginia, Charlottesville, Virginia, United States
  • Mohammad, Saleh, University of Virginia, Charlottesville, Virginia, United States
  • Loi, Valentina, AO Brotzu Cagliari, Cagliari, Italy
  • Mandziak, Ewa U., University of Virginia, Charlottesville, Virginia, United States
  • Swaminathan, Sundararaman, University of Virginia, Charlottesville, Virginia, United States

Acute Kidney injury is a frequent complication of Sepsis and is associated with increased comorbidity and mortality. A new paradigm of sepsis-induced AKI suggest that responses to tubular injury with an uncontrolled pro-inflammatory response (TNFα, IL-6, IL-10) can further renal damage. Previously we have shown that Hepcidin (Hamp), an endogenous peptide which controls systemic and local iron homeostasis, ameliorates ischemia-reperfusion injury and LPS induced AKI, by reducing renal oxidative stress, inflammation and apoptosis. DJ-1 is an anti-oxidant protein that is expressed in the brain and kidney and known to reduce oxidative stress via multiple mechanisms. Importantly it is a positive regulator of glutathione peroxidase 4 (GPX-4) a protein implicated in Ferroptosis (Iron-mediated cell death).


C57BLK/6 (WT) and DJ-1 knockout mice on B6 background were injected with PBS or 50 ug of Hamp (i.p) and 24 hours later administered 6.5mg/kg LPS (i.p). Tissue were harvested 24 hours after LPS administration for measuring renal function, injury, and inflammation.


Compared to PBS, Hamp pretreated WT mice were protected against LPS-induced AKI as indicated by significantly lower plasma creatinine (WT PBS+ LPS 1.11 ± 0.17 Vs Hamp + LPS 0.41 ± 0.03; p= <0.0001), NGAL and KIM-1 levels. Hamp + LPS treated animals also had less infiltrating neutrophils and CD11b positive cells compared to PBS + LPS treated ones. Hamp + LPS treated mice had significantly lower splenic IL-6, IL-10 and IL-22 mRNA levels compared to PBS + LPS. In contrast to WT mice, Hamp failed to protect DJ-1 KO mice against LPS induced AKI. DJ-1 KO mice treated with PBS or Hamp had comparable plasma creatinine (DJ-1 KO PBS + LPS; .95 ± 0.06 Vs Hamp + LPS 0.85 ± 0.15; p= 0.7776), NGAL, KIM-1 and infiltrating cells. The splenic inflammatory signature was also comparable between the two groups.


Hepcidin protects against LPS-induced AKI by reducing systemic inflammation. The protective effect of Hamp seems to be dependent DJ-1, as loss of DJ-1 in mice abrogated Hamp`s protective effect.


  • Other NIH Support